| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Widecells Group Plc | LSE:WDC | London | Ordinary Share | GB00BD060S65 | ORD GBP0.0025 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.285 | 0.28 | 0.29 | 0.00 | 01:00:00 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Health & Allied Services,nec | 0.0 | -0.8 | - | - | 106.60 |
Iconic Labs PLC Restoration of Trading
25/01/2023 12:08pm
UK Regulatory (RNS & others)
Widecells (LSE:WDC)
Historical Stock Chart
From Dec 2022 to Jun 2023
TIDMICON
RNS Number : 8611N
Iconic Labs PLC
25 January 2023
Iconic Labs PLC
("Iconic" or the "Company")
Restoration of Trading
Iconic Labs PLC (LSE:ICON), a multi-divisional new media and technology business, is pleased to announce that the Financial Conduct Authority has lifted the suspension of the listing in the Company's ordinary shares and as a result shareholders can once again trade the Company's shares on the London Stock Exchange.
Using the funds secured through the GBP 3 million European High Growth Opportunities Securitization Fund financing facility, the Company will continue to fulfill its obligations under the Company Voluntary Agreement and resume the implementation of its corporate plans.
Iconic's CEO, Brad Taylor stated:
"Iconic has been successfully restructured, we have financing in place, and the trading suspension has been lifted. The Company is now working to formalise terms with the various parties that we have been speaking with over the last few months, but who understandably would not formalise discussions until the trading suspension was lifted. I look forward to updating shareholders as these conversations progress."
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For any further information or enquiries please contact:
www.iconiclabs.co.uk
ir@iconiclabs.co.uk
Iconic Labs PLC
3 Field Court, WC1R 5EF London
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RENGZGZMZKDGFZM
(END) Dow Jones Newswires
January 25, 2023 07:08 ET (12:08 GMT)
1 Year Widecells Chart |
1 Month Widecells Chart |